Induction of human pluripotent stem cells into kidney tissues by synthetic mRNAs encoding transcription factors-Reference-Cited by-同舟云学术

Induction of human pluripotent stem cells into kidney tissues by synthetic mRNAs encoding transcription factors

Published:2019-01-29 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Hiratsuka Ken,Monkawa Toshiaki^ORCID,Akiyama Tomohiko,Nakatake Yuhki,Oda Mayumi^ORCID,Goparaju Sravan Kumar,Kimura Hiromi,Chikazawa-Nohtomi Nana,Sato Saeko,Ishiguro Keiichiro^ORCID,Yamaguchi Shintaro,Suzuki Sayuri,Morizane Ryuji^ORCID,Ko Shigeru B. H.,Itoh Hiroshi,Ko Minoru S. H.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-37485-8.pdf

Reference67 articles.

1. Jha, V. et al. Chronic kidney disease: global dimension and perspectives. The Lancet 382, 260–272 (2013).

2. Coresh, J. et al. Prevalence of chronic kidney disease in the United States. J. Am. Med. Assoc. 298, 2038–2047 (2007).

3. Morizane, R. & Bonventre, J. V. Kidney Organoids: A Translational Journey. Trends Mol. Med. 23, 246–263 (2017).

4. Morizane, R., Miyoshi, T. & Bonventre, J. V. Concise Review: Kidney Generation with Human Pluripotent Stem Cells. Stem Cells 35, 2209–2217 (2017).

5. Little, M. H., Combes, A. N. & Takasato, M. Understanding kidney morphogenesis to guide renal tissue regeneration. Nat. Rev. Nephrol. 12, 624–635 (2016).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic applications of cell engineering using mRNA technology;Trends in Biotechnology;2024-08

2. Cryopreservation of human kidney organoids;Cellular and Molecular Life Sciences;2024-07-18

3. Renal Tubular Epithelium in the Development of Renal Cell Carcinoma;2024-06-26

4. Evaluation of the impact of iPSC differentiation protocols on transcriptomic signatures;Toxicology in Vitro;2024-06

5. Advances in the Treatment of Kidney Disorders using Mesenchymal Stem Cells;Current Pharmaceutical Design;2024-03